Cite
HARVARD Citation
Bruhn, M. et al. (n.d.). Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer. International journal of cancer. 135 (3), pp. 731-741. [Online].